Martens Rachel Yap
SEC CIK 2071589 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | SVP, Partnerships, Corp Strat | 31.3K | — | — | 2 | 2026-02-28 | 2026-02-28 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Martens Rachel Yap | SVP, Partnerships, Corp Strat | F - Tax | $1.47 | -35.8K | 31.3K | -53% | -$52.7K |
| D | 2026-03-03 | 2026-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Martens Rachel Yap | SVP, Partnerships, Corp Strat | M - OptEx | — | +67.1K | 67.1K | New | — |
Purchase Sale Sale after option exercise All abbreviations